Meanwhile, transwell assays also confirmed that dysregulation of CREB3L2 could affect the migration and invasion ability of respective HCC cells (Fig. 2I, J, Supplementary Fig. S2F, G). This evidence concerns the gene CREB3L2 and hepatocellular carcinoma.